Comparison of bispectral index-guided and fixed-gas concentration techniques in desflurane and remifentanil anesthesia: A randomized controlled trial

Seong Mi Yang, Yoo Sun Jung, Chul-Woo Jung, Won Ho Kim, Soo Bin Yoon, Hyung-Chul Lee, Seong Mi Yang, Yoo Sun Jung, Chul-Woo Jung, Won Ho Kim, Soo Bin Yoon, Hyung-Chul Lee

Abstract

Anesthesia with desflurane and remifentanil can be maintained with either fixed or titrated desflurane concentration. We hypothesized that the fixed-gas concentration (FG) method would reduce the number of anesthetic titrations without hypnotic and hemodynamic instability compared to the bispectral index (BIS)-guided (BG) method. Forty-eight patients were randomly allocated to the FG or BG groups. In the FG group, desflurane vaporizer setting was fixed at 1 age-corrected minimum alveolar concentration (MAC). In the BG group, desflurane was titrated to target a BIS level at 50. Remifentanil was titrated to maintain a systolic arterial pressure (SAP) of 120 mmHg in both groups. Our primary endpoint was the hypnotic stability measured by the wobble of BIS in performance analysis, and the secondary endpoints included the wobble of SAP, mean BIS value during surgery, and the number of anesthetic titrations. The BIS in the FG group showed significantly less wobble (3.9 ± 1.1% vs 5.5 ± 1.5%, P <0.001) but lower value (33 ± 6 vs 46 ± 7, P <0.001) than BG group. The wobble of SAP showed no difference between groups [median (inter-quartile range), 5.0 (4.1-7.5)% vs 5.2 (4.2-8.3)%, P = 0.557]. The numbers of anesthetic titrations in the FG group were significantly lower than the BG group (0 ± 0 vs 8 ± 5, P<0.001 for desflurane, 13 ± 13 vs 22 ± 17, P = 0.047 for remifentanil). Less wobble in BIS and reduced anesthetic titration without hemodynamic instability during the FG technique may be practical in balanced anesthesia using desflurane and remifentanil anesthesia. Clinical trial: This study was registered at ClinicalTrials.gov (NCT02283866).

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. CONSORT diagram.
Fig 1. CONSORT diagram.
Fig 2. Changes of desflurane and remifentanil…
Fig 2. Changes of desflurane and remifentanil target concentrations during balanced anesthesia in typical patients.
A: the 7th patient in the bispectral index-guided group; B: the 12th patient in the fixed-gas concentration group. End-tidal concentrations of desflurane and target effect-site concentrations of remifentanil changed during the study period, showing significant difference in the number of titrations between two groups.
Fig 3. Recovery times defined by different…
Fig 3. Recovery times defined by different measures like OAA/S score, eye-opening and extubation.
Recovery time was defined as the elapsed time between cessation of desflurane and remifentanil and occurrence of recovery signs like OAA/S score >2, opening of eyes to verbal command, or spontaneous ventilation. Extubation was performed immediately after the notice of spontaneous ventilation and means final recovery in this study. Kaplan-Meier survival analysis with log rank test for pairwise comparison reveals that there are no between-group differences regarding three recovery times. Abbreviation: OAA/S = observer’s assessment of alertness/sedation.
Fig 4. Desflurane-remifentanil concentration combination.
Fig 4. Desflurane-remifentanil concentration combination.
Scatter plots represent average (dot) and SD (error bars) of desflurane-remifentanil concentration combinations. The bidirectional error bars represent the variability of desflurane (vertical error bar) and remifentanil (horizontal error bar) concentrations. The fixed-gas concentration group shows higher desflurane and lower remifentanil concentrations with shorter error bars than the bispectral index-guided group.

References

    1. Tonner PH. Balanced anaesthesia today. Best Pract Res Clin Anaesthesiol. 2005;19(3):475–84. 10.1016/j.bpa.2005.02.005
    1. Kong CF, Chew ST, Ip-Yam PC. Intravenous opioids reduce airway irritation during induction of anaesthesia with desflurane in adults. Br J Anaesth. 2000;85(3):364–7. 10.1093/bja/85.3.364
    1. Sebel PS, Glass PS, Fletcher JE, Murphy MR, Gallagher C, Quill T. Reduction of the MAC of desflurane with fentanyl. Anesthesiology. 1992;76(1):52–9. 10.1097/00000542-199201000-00008
    1. Song D, White PF. Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth. 1999;11(5):364–7. 10.1016/s0952-8180(99)00061-6
    1. Guignard B. Monitoring analgesia. Best Pract Res Clin Anaesthesiol. 2006;20(1):161–80. 10.1016/j.bpa.2005.09.002
    1. Manyam SC, Gupta DK, Johnson KB, White JL, Pace NL, Westenskow DR, et al. Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology. 2006;105(2):267–78. 10.1097/00000542-200608000-00009
    1. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. Journal of pharmacokinetics and biopharmaceutics. 1992;20(1):63–94. 10.1007/BF01143186
    1. Lee HC, Ryu HG, Jung CW. Performance measurement of intraoperative systolic arterial pressure to predict in-hospital mortality in adult liver transplantation. Sci Rep. 2017;7(1):7030 10.1038/s41598-017-07664-0
    1. Struys MM, De Smet T, Versichelen LF, Van De Velde S, Van den Broecke R, Mortier EP. Comparison of closed-loop controlled administration of propofol using Bispectral Index as the controlled variable versus "standard practice" controlled administration. Anesthesiology. 2001;95(1):6–17. 10.1097/00000542-200107000-00007
    1. Hemmerling TM, Arbeid E, Wehbe M, Cyr S, Taddei R, Zaouter C. Evaluation of a novel closed-loop total intravenous anaesthesia drug delivery system: a randomized controlled trial. Br J Anaesth. 2013;110(6):1031–9. 10.1093/bja/aet001
    1. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86(1):10–23. 10.1097/00000542-199701000-00004
    1. Mapleson W. Effect of age on MAC in humans: a meta-analysis. British Journal of Anaesthesia. 1996;76(2):179–85.
    1. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and Reliability of the Observer's: Assessment of Alertness/Sedation Scale: Study with: Intravenous Midazolam. Journal of clinical psychopharmacology. 1990;10(4):244–51.
    1. Lee HC, Jung CW. Vital Recorder-a free research tool for automatic recording of high-resolution time-synchronised physiological data from multiple anaesthesia devices. Sci Rep. 2018;8(1):1527 10.1038/s41598-018-20062-4
    1. Liu N, Chazot T, Genty A, Landais A, Restoux A, McGee K, et al. Titration of propofol for anesthetic induction and maintenance guided by the bispectral index: closed-loop versus manual control: a prospective, randomized, multicenter study. Anesthesiology. 2006;104(4):686–95. 10.1097/00000542-200604000-00012
    1. Biro P. Calculation of volatile anaesthetics consumption from agent concentration and fresh gas flow. Acta Anaesthesiol Scand. 2014;58(8):968–72. 10.1111/aas.12374
    1. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91. 10.3758/bf03193146
    1. Nel MR, Ooi R, Lee DJ, Soni N. New agents, the circle system and short procedures. Anaesthesia. 1997;52(4):364–7. 10.1111/j.1365-2044.1997.az0083a.x
    1. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens H, Gambus P, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86(1):10–23. 10.1097/00000542-199701000-00004
    1. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesthesia and analgesia. 2005;100(1):4–10. 10.1213/01.ANE.0000147519.82841.5E
    1. Leslie K, Myles PS, Forbes A, Chan MT. The effect of bispectral index monitoring on long-term survival in the B-aware trial. Anesthesia and analgesia. 2010;110(3):816–22. 10.1213/ANE.0b013e3181c3bfb2
    1. Leslie K, Short TG. Anesthetic depth and long-term survival: an update. Can J Anaesth. 2016;63(2):233–40. 10.1007/s12630-015-0490-0
    1. Short TG, Leslie K, Chan MT, Campbell D, Frampton C, Myles P. Rationale and Design of the Balanced Anesthesia Study: A Prospective Randomized Clinical Trial of Two Levels of Anesthetic Depth on Patient Outcome After Major Surgery. Anesthesia and analgesia. 2015;121(2):357–65. 10.1213/ANE.0000000000000797
    1. Ghoneim MM. Awareness during anesthesia. Anesthesiology. 2000;92(2):597–602. 10.1097/00000542-200002000-00043
    1. Gonsowski CT, Chortkoff BS, Eger EI, 2nd, Bennett HL, Weiskopf RB. Subanesthetic concentrations of desflurane and isoflurane suppress explicit and implicit learning. Anesth Analg. 1995;80(3):568–72. 10.1097/00000539-199503000-00024
    1. Weiskopf RB, Sampson D, Moore MA. The desflurane (Tec 6) vaporizer: design, design considerations and performance evaluation. Br J Anaesth. 1994;72(4):474–9. 10.1093/bja/72.4.474
    1. Radtke FM, Franck M, Lendner J, Kruger S, Wernecke KD, Spies CD. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth. 2013;110 Suppl 1:i98–105.
    1. Kertai MD, White WD, Gan TJ. Cumulative duration of "triple low" state of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia is not associated with increased mortality. Anesthesiology. 2014;121(1):18–28. 10.1097/ALN.0000000000000281
    1. Hart SG, Staveland LE. Development of NASA-TLX (Task Load Index): Results of Empirical and Theoretical Research. Human Mental Workload. Advances in Psychology. 1988. p. 139–83.
    1. Coppens MJ, Versichelen LF, Mortier EP, Struys MM. Do we need inhaled anaesthetics to blunt arousal, haemodynamic responses to intubation after i.v. induction with propofol, remifentanil, rocuronium? Br J Anaesth. 2006;97(6):835–41. 10.1093/bja/ael254

Source: PubMed

3
Subskrybuj